# CollPlant Biotechnologies Ltd. (CLGN)

> Healthcare · IL · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/CLGN/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 73.0K | $ -3.10M | $ -3.06M | $ 2.65M | $ 4.89M |
| 2025 | $ 2.43M | $ -11.76M | $ -9.96M | $ 2.85M | $ 6.08M |
| 2024 | $ 541.3K | $ -17.46M | $ -15.32M | $ 3.08M | $ 13.47M |
| 2023 | $ 11.85M | $ -7.59M | $ -4.02M | $ 3.16M | $ 28.34M |
| 2022 | $ 334.0K | $ -18.91M | $ -16.73M | $ 2.91M | $ 32.28M |
| 2021 | $ 18.59M | $ 281.7K | $ 1.28M | $ 3.61M | $ 45.12M |
| 2020 | $ 7.82M | $ -7.36M | $ -6.23M | $ 3.39M | $ 4.48M |
| 2019 | $ 2.99M | $ -14.01M | $ -9.48M | $ 3.62M | $ 4.09M |
| 2018 | $ 6.36M | $ -5.24M | $ -3.15M | $ 44.6K | $ 4.76M |
| 2017 | $ 640.7K | $ -7.83M | $ -6.98M | $ 3.64M | $ 2.61M |
| 2016 | $ 104.4K | $ -9.99M | $ -7.18M | $ 0 | $ 1.34M |
| 2015 | $ 0 | $ -5.67M | $ -5.75M | $ 0 | $ 2.51M |
| 2014 | $ 0 | $ -5.09M | $ -5.20M | $ 0 | $ 3.68M |
| 2013 | $ 0 | $ -6.57M | $ -5.47M | $ 0 | $ 7.81M |
| 2012 | $ 0 | $ -3.54M | $ -3.11M | $ 0 | $ 4.20M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.54 |
| Liabilities / Eq | 0.88 |
| Current Ratio | 2.27 |

## Other views

- [Metrics](https://sponda.capital/en/CLGN.md)
- [Charts](https://sponda.capital/en/CLGN/charts.md)
- [Compare](https://sponda.capital/en/CLGN/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.